TTK Healthcare Limited (TTKHLTCARE.NS)

INR 1456.8

(-2.39%)

Operating Expenses Summary of TTK Healthcare Limited

  • TTK Healthcare Limited's latest annual operating expenses in 2023 was 3.72 Billion INR , down -31.89% from previous year.
  • TTK Healthcare Limited's latest quarterly operating expenses in 2024 Q2 was 1.02 Billion INR , down -9.28% from previous quarter.
  • TTK Healthcare Limited reported a annual operating expenses of 3.58 Billion INR in annual operating expenses 2022, up 19.76% from previous year.
  • TTK Healthcare Limited reported a annual operating expenses of 2.99 Billion INR in annual operating expenses 2021, down -16.28% from previous year.
  • TTK Healthcare Limited reported a quarterly operating expenses of 1.02 Billion INR for 2024 Q2, down -9.28% from previous quarter.
  • TTK Healthcare Limited reported a quarterly operating expenses of 524.12 Million INR for 2023 Q4, down -45.54% from previous quarter.

Annual Operating Expenses Chart of TTK Healthcare Limited (2023 - 2004)

Historical Annual Operating Expenses of TTK Healthcare Limited (2023 - 2004)

Year Operating Expenses Operating Expenses Growth
2023 3.72 Billion INR -31.89%
2022 3.58 Billion INR 19.76%
2021 2.99 Billion INR -16.28%
2020 3.57 Billion INR -2.74%
2019 3.67 Billion INR 12.93%
2018 3.25 Billion INR 6.73%
2017 3.05 Billion INR 18.18%
2016 2.58 Billion INR 2.76%
2015 2.51 Billion INR 5.39%
2014 2.38 Billion INR 17.4%
2013 2.03 Billion INR 16.63%
2012 1.74 Billion INR 22.72%
2011 1.41 Billion INR 13.04%
2010 1.25 Billion INR 22.72%
2009 1.02 Billion INR 17.6%
2008 870.06 Million INR 38.21%
2007 629.52 Million INR -14.95%
2006 740.21 Million INR 11.56%
2005 663.5 Million INR 15.87%
2004 572.64 Million INR 0.0%

Peer Operating Expenses Comparison of TTK Healthcare Limited

Name Operating Expenses Operating Expenses Difference
Abbott India Limited 5.98 Billion INR 37.834%
Cipla Limited 59.21 Billion INR 93.716%
Gland Pharma Limited 14.65 Billion INR 74.609%
GlaxoSmithKline Pharmaceuticals Limited 4.35 Billion INR 14.596%
Kopran Limited 1.41 Billion INR -162.845%
Marksans Pharma Limited 3.28 Billion INR -13.13%
NGL Fine-Chem Limited 1.75 Billion INR -112.618%
Pfizer Limited 4.33 Billion INR 14.199%
Sanofi India Limited 4.13 Billion INR 9.938%
SMS Pharmaceuticals Limited 769.2 Million INR -383.792%